Do Antidepressants Induce Metabolic Syndromes METADAP Study
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
Since antidepressants and antipsychotics have common receptorial mechanisms of action (H1
antagonism, 5HT2 antagonism), the impact of antidepressants in terms of metabolic syndromes
is a matter of concern.
The main objective of this study is to assess the differential impact of antidepressants in
terms of weight gain and metabolic syndromes.
Phase:
N/A
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborator:
Institut National de la Santé Et de la Recherche Médicale, France